Trial Outcomes & Findings for A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases. (NCT NCT00728754)
NCT ID: NCT00728754
Last Updated: 2024-08-20
Results Overview
Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.
COMPLETED
NA
61 participants
1 year
2024-08-20
Participant Flow
Up to 120 patients were enrolled across all centers, with enrollment efforts beginning in February 2005. Enrollment period remained open until June 2006. Two participating sites were Universities and four were private practices.
Pre-treatment included a screening visit (enroll those meeting all inclusion criteria), signing informed consent, and pre-surgical data collection.Patients returned for implant placement surgery, followed by temporary prosthesis placement at 2 months.
Participant milestones
| Measure |
Osseotite Certain Prevail Implant
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
|
Osseotite Certain Implant
Patients with dental implant with internal connection and without the lateralized expanded platform design
|
|---|---|---|
|
Implant Placement Surgery
STARTED
|
29
|
32
|
|
Implant Placement Surgery
COMPLETED
|
29
|
32
|
|
Implant Placement Surgery
NOT COMPLETED
|
0
|
0
|
|
Permanent Prosthesis Placement
STARTED
|
29
|
32
|
|
Permanent Prosthesis Placement
COMPLETED
|
25
|
28
|
|
Permanent Prosthesis Placement
NOT COMPLETED
|
4
|
4
|
|
One Year Post Placement Follow-up
STARTED
|
25
|
28
|
|
One Year Post Placement Follow-up
COMPLETED
|
24
|
28
|
|
One Year Post Placement Follow-up
NOT COMPLETED
|
1
|
0
|
|
Two Year Post Placement Follow-up
STARTED
|
24
|
28
|
|
Two Year Post Placement Follow-up
COMPLETED
|
24
|
28
|
|
Two Year Post Placement Follow-up
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
| Measure |
Osseotite Certain Prevail Implant
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
|
Osseotite Certain Implant
Patients with dental implant with internal connection and without the lateralized expanded platform design
|
|---|---|---|
|
Permanent Prosthesis Placement
Adverse Event
|
1
|
1
|
|
Permanent Prosthesis Placement
Lost to Follow-up
|
3
|
3
|
|
One Year Post Placement Follow-up
Adverse Event
|
1
|
0
|
Baseline Characteristics
A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.
Baseline characteristics by cohort
| Measure |
Osseotite Certain Prevail Implant
n=29 Participants
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
|
Osseotite Certain Implant
n=32 Participants
Patients with dental implant with internal connection and without the lateralized expanded platform design
|
Total
n=61 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
<=18 years
|
0 participants
n=99 Participants
|
0 participants
n=107 Participants
|
0 participants
n=206 Participants
|
|
Age, Customized
Between 18 and 65 years
|
18 participants
n=99 Participants
|
21 participants
n=107 Participants
|
39 participants
n=206 Participants
|
|
Age, Customized
>=65 years
|
11 participants
n=99 Participants
|
11 participants
n=107 Participants
|
22 participants
n=206 Participants
|
|
Sex/Gender, Customized
Female
|
14 participants
n=99 Participants
|
15 participants
n=107 Participants
|
29 participants
n=206 Participants
|
|
Sex/Gender, Customized
Male
|
15 participants
n=99 Participants
|
17 participants
n=107 Participants
|
32 participants
n=206 Participants
|
|
Region of Enrollment
United States
|
6 participants
n=99 Participants
|
8 participants
n=107 Participants
|
14 participants
n=206 Participants
|
|
Region of Enrollment
Italy
|
15 participants
n=99 Participants
|
15 participants
n=107 Participants
|
30 participants
n=206 Participants
|
|
Region of Enrollment
Sweden
|
5 participants
n=99 Participants
|
4 participants
n=107 Participants
|
9 participants
n=206 Participants
|
|
Region of Enrollment
Australia
|
3 participants
n=99 Participants
|
5 participants
n=107 Participants
|
8 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 1 yearPopulation: population analyzed was all patients receiving implants enrolled in the study, those reported here actually represent the number of implants being followed at the 12 month follow-up time point (time of analysis).
Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.
Outcome measures
| Measure |
Osseotite Certain Prevail Implant
n=65 implants
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
|
Osseotite Certain Implant
n=68 implants
Patients with dental implant with internal connection and without the lateralized expanded platform design
|
|---|---|---|
|
Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit
|
-0.7440 millimeters
Standard Error 0.1881
|
-0.8445 millimeters
Standard Error 0.1439
|
SECONDARY outcome
Timeframe: four yearsOutcome measures
Outcome data not reported
Adverse Events
Osseotite Certain Prevail Implant
Osseotite Certain Implant
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Osseotite Certain Prevail Implant
n=29 participants at risk
Patients with dental implant with internal connection and expanded, lateralized design at coronal portion
|
Osseotite Certain Implant
n=32 participants at risk
Patients with dental implant with internal connection and without the lateralized expanded platform design
|
|---|---|---|
|
Surgical and medical procedures
Loss of integration of implant
|
17.2%
5/29 • Number of events 5 • Adverse events are collected and reported from day 1 of the study to present, 4 years of study duration to date.
Adverse event data is collected by patient questioning and visual examination of patient's mouth each study event visit.
|
15.6%
5/32 • Number of events 5 • Adverse events are collected and reported from day 1 of the study to present, 4 years of study duration to date.
Adverse event data is collected by patient questioning and visual examination of patient's mouth each study event visit.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
- Publication restrictions are in place
Restriction type: OTHER